Repository logo
  • English
  • 中文
Log In
Have you forgotten your password?
  1. Home
  2. College of Medicine / 醫學院
  3. School of Medicine / 醫學系
  4. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
 
  • Details

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD

Journal
International Journal of COPD
Journal Volume
13
Pages
867-874
Date Issued
2018
Author(s)
Lai C.-C.
Wang Y.-H.
Wang C.-Y.
HAO-CHIEN WANG  
CHONG-JEN YU  
Chen L.
Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE)
DOI
10.2147/COPD.S158634
URI
https://www.scopus.com/inward/record.uri?eid=2-s2.0-85044382573&doi=10.2147%2fCOPD.S158634&partnerID=40&md5=b26552565601e59dc1df90c81ccbf377
https://scholars.lib.ntu.edu.tw/handle/123456789/512196
Abstract
Objectives: This study aimed to compare the effects of angiotensin-converting-enzyme inhibitors (ACEis) and angiotensin receptor blockers (ARBs) on the risk of pneumonia and severe exacerbations in patients with COPD. Patients and methods: All patients with COPD who used ACEis and ARBs for >90 days between 2000 and 2005 were recruited. Pairwise matching (1:1) of the ACEi and ARB groups resulted in two similar subgroups, with 6,226 patients in each. The primary outcomes were pneumonia and COPD exacerbations, and the secondary outcome was death. Results: During the follow-up period, the incidence of pneumonia was 7.20 per 100 person-years in the ACEi group and 5.89 per 100 person-years in the ARB group. The ACEi group had a higher risk of pneumonia (adjusted hazard ratio [aHR], 1.22; 95% CI, 1.15–1.29) than the ARB group. The incidence of severe exacerbations was 0.65 per person-year for the patients receiving ACEis and 0.52 per person-year for those receiving ARBs. The patients receiving ACEis had a higher risk of severe exacerbations (aHR, 1.19; 95% CI, 1.16–1.21) than those receiving ARBs. Similar trends were noted in terms of severe exacerbations requiring hospitalization (aHR, 1.24; 95% CI, 1.21–1.28) or emergency department visits (aHR, 1.16; 95% CI, 1.13–1.18), pneumonia requiring mechanical ventilation (aHR, 1.35; 95% CI, 1.24–1.47), and mortality (aHR, 1.33; 95% CI, 1.26–1.42). Conclusion: ARBs were associated with lower rates of pneumonia, severe pneumonia, and mortality than ACEis in patients with COPD. ? 2018 Lai et al.
SDGs

[SDGs]SDG3

Other Subjects
angiotensin receptor antagonist; dipeptidyl carboxypeptidase inhibitor; angiotensin 1 receptor antagonist; dipeptidyl carboxypeptidase inhibitor; aged; Article; artificial ventilation; chronic obstructive lung disease; cohort analysis; comparative effectiveness; controlled study; death; disease association; disease exacerbation; drug sensitivity; emergency ward; female; follow up; high risk population; hospitalization; human; incidence; major clinical study; male; mortality rate; outcome assessment; pneumonia; treatment duration; administrative claims (health care); chronic obstructive lung disease; comparative study; disease exacerbation; factual database; middle aged; mortality; pneumonia; prognosis; proportional hazards model; protection; risk assessment; risk factor; Taiwan; time factor; Administrative Claims, Healthcare; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Databases, Factual; Disease Progression; Female; Humans; Incidence; Male; Middle Aged; Pneumonia; Prognosis; Proportional Hazards Models; Protective Factors; Pulmonary Disease, Chronic Obstructive; Risk Assessment; Risk Factors; Taiwan; Time Factors
Publisher
Dove Medical Press Ltd.
Type
journal article

臺大位居世界頂尖大學之列,為永久珍藏及向國際展現本校豐碩的研究成果及學術能量,圖書館整合機構典藏(NTUR)與學術庫(AH)不同功能平台,成為臺大學術典藏NTU scholars。期能整合研究能量、促進交流合作、保存學術產出、推廣研究成果。

To permanently archive and promote researcher profiles and scholarly works, Library integrates the services of “NTU Repository” with “Academic Hub” to form NTU Scholars.

總館學科館員 (Main Library)
醫學圖書館學科館員 (Medical Library)
社會科學院辜振甫紀念圖書館學科館員 (Social Sciences Library)

開放取用是從使用者角度提升資訊取用性的社會運動,應用在學術研究上是透過將研究著作公開供使用者自由取閱,以促進學術傳播及因應期刊訂購費用逐年攀升。同時可加速研究發展、提升研究影響力,NTU Scholars即為本校的開放取用典藏(OA Archive)平台。(點選深入了解OA)

  • 請確認所上傳的全文是原創的內容,若該文件包含部分內容的版權非匯入者所有,或由第三方贊助與合作完成,請確認該版權所有者及第三方同意提供此授權。
    Please represent that the submission is your original work, and that you have the right to grant the rights to upload.
  • 若欲上傳已出版的全文電子檔,可使用Open policy finder網站查詢,以確認出版單位之版權政策。
    Please use Open policy finder to find a summary of permissions that are normally given as part of each publisher's copyright transfer agreement.
  • 網站簡介 (Quickstart Guide)
  • 使用手冊 (Instruction Manual)
  • 線上預約服務 (Booking Service)
  • 方案一:臺灣大學計算機中心帳號登入
    (With C&INC Email Account)
  • 方案二:ORCID帳號登入 (With ORCID)
  • 方案一:定期更新ORCID者,以ID匯入 (Search for identifier (ORCID))
  • 方案二:自行建檔 (Default mode Submission)
  • 方案三:學科館員協助匯入 (Email worklist to subject librarians)

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science